News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
241,205 Results
Type
Article (7779)
Company Profile (53)
Press Release (233371)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (72526)
Career Advice (232)
Deals (15792)
Drug Delivery (14)
Drug Development (31008)
Employer Resources (13)
FDA (5205)
Job Trends (5462)
News (123351)
Policy (10719)
Tag
2027 Pharm Country Standard (1)
Academia (806)
Accelerated approval (19)
Adcomms (1)
Allergies (48)
Alliances (12312)
ALS (60)
Alzheimer's disease (652)
Antibody-drug conjugate (ADC) (123)
Approvals (5489)
Artificial intelligence (129)
Autoimmune disease (63)
Automation (14)
Bankruptcy (120)
Best Places to Work (4984)
BIOSECURE Act (3)
Biosimilars (27)
Biotechnology (33)
Bladder cancer (67)
Brain cancer (22)
Breast cancer (275)
Cancer (1995)
Cardiovascular disease (160)
Career advice (209)
Career pathing (4)
CAR-T (101)
CDC (3)
Cell therapy (238)
Cervical cancer (14)
Clinical research (27582)
Collaboration (443)
Company closure (1)
Compensation (304)
Complete response letters (14)
COVID-19 (1195)
CRISPR (26)
C-suite (181)
Cystic fibrosis (52)
Data (3013)
Decentralized trials (1)
Denatured (1)
Depression (74)
Diabetes (174)
Diagnostics (2525)
Digital health (17)
Diversity, equity & inclusion (1)
Drug discovery (57)
Drug pricing (11)
Drug shortages (3)
Duchenne muscular dystrophy (76)
Earnings (47851)
Editorial (10)
Employer branding (3)
Employer resources (13)
Events (40490)
Executive appointments (202)
FDA (6597)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (12)
Funding (320)
Gene editing (53)
Generative AI (4)
Gene therapy (141)
GLP-1 (276)
Government (1623)
Grass and pollen (3)
Guidances (329)
Healthcare (7542)
HIV (28)
Huntington's disease (15)
IgA nephropathy (28)
Immunology and inflammation (70)
Immuno-oncology (19)
Indications (67)
Infectious disease (1297)
Inflammatory bowel disease (77)
Influenza (43)
Intellectual property (90)
Interviews (38)
IPO (10421)
IRA (3)
Job creations (678)
Job search strategy (179)
JPM (9)
Kidney cancer (7)
Labor market (21)
Layoffs (108)
Leadership (5)
Legal (2074)
Liver cancer (35)
Longevity (11)
Lung cancer (277)
Lymphoma (176)
Machine learning (12)
Management (5)
Manufacturing (175)
MASH (84)
Medical device (5584)
Medtech (5605)
Mergers & acquisitions (5805)
Metabolic disorders (428)
mRNA (27)
Multiple sclerosis (55)
NASH (10)
Neurodegenerative disease (133)
Neuropsychiatric disorders (28)
Neuroscience (1091)
NextGen: Class of 2026 (1715)
Non-profit (1368)
Now hiring (8)
Obesity (163)
Opinion (24)
Ovarian cancer (80)
Pain (62)
Pancreatic cancer (100)
Parkinson's disease (98)
Partnered (8)
Patents (163)
Patient recruitment (139)
Peanut (22)
People (14542)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase 1 (7792)
Phase 2 (12029)
Phase 3 (10271)
Pipeline (3431)
Policy (26)
Postmarket research (889)
Preclinical (2876)
Press Release (15)
Prostate cancer (94)
Psychedelics (7)
Radiopharmaceuticals (123)
Rare diseases (296)
Real estate (1249)
Recruiting (7)
Regulatory (8660)
Reports (11)
Research institute (653)
Resumes & cover letters (23)
Rett syndrome (10)
RNA editing (4)
RSV (33)
Schizophrenia (71)
Series A (48)
Series B (39)
Service/supplier (6)
Sickle cell disease (31)
Special edition (10)
Spinal muscular atrophy (83)
Sponsored (7)
Startups (670)
State (1)
Stomach cancer (1)
Supply chain (30)
Tariffs (12)
The Weekly (4)
Vaccines (284)
Venture capital (17)
Weight loss (82)
Women's health (25)
Worklife (2)
Date
Today (74)
Last 7 days (225)
Last 30 days (1122)
Last 365 days (10976)
2026 (2476)
2025 (11240)
2024 (13243)
2023 (15223)
2022 (18850)
2021 (20145)
2020 (41848)
2019 (15553)
2018 (10708)
2017 (10568)
2016 (8599)
2015 (11218)
2014 (7529)
2013 (5238)
2012 (6057)
2011 (6579)
2010 (5737)
Location
Africa (151)
Alabama (36)
Alaska (1)
Arizona (89)
Arkansas (1)
Asia (14585)
Australia (2130)
California (4691)
Canada (1019)
China (419)
Colorado (222)
Connecticut (241)
Delaware (183)
Europe (30017)
Florida (706)
Georgia (118)
Idaho (11)
Illinois (341)
India (15)
Indiana (247)
Iowa (4)
Japan (178)
Kansas (75)
Kentucky (10)
Louisiana (20)
Maine (32)
Maryland (520)
Massachusetts (2976)
Michigan (108)
Minnesota (222)
Mississippi (1)
Missouri (70)
Montana (8)
Nebraska (6)
Nevada (30)
New Hampshire (25)
New Jersey (1539)
New Mexico (6)
New York (1263)
North Carolina (443)
North Dakota (5)
Northern California (2344)
Ohio (112)
Oklahoma (2)
Oregon (6)
Pennsylvania (1008)
Puerto Rico (1)
Rhode Island (5)
South America (273)
South Carolina (11)
Southern California (1892)
Tennessee (36)
Texas (747)
United States (16272)
Utah (125)
Virginia (119)
Washington D.C. (7)
Washington State (331)
West Virginia (1)
Wisconsin (24)
241,205 Results for "21".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos
Following last month’s $7.8 billion purchase of CAR T biotech Arcellx, Gilead’s dealmaking train chugs along with yet another acquisition—this time securing Ouro Medicines’ pipeline of T cell engagers for inflammatory diseases.
March 24, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026
March 19, 2026
·
1 min read
Weight loss
Novo Leans Into Oral Route With Weight Loss Partnership Worth up to $2.1B
After its next-generation obesity asset CagriSema lost a head-to-head matchup with Eli Lilly’s Zepbound, Novo Nordisk is throwing more money into the obesity space, striking a deal with Vivtex to advance novel weight loss pills.
February 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
March 26, 2026
·
28 min read
Press Releases
Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026
January 14, 2026
·
4 min read
Press Releases
Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics
January 13, 2026
·
8 min read
Press Releases
Nimbus Therapeutics to Present Preclinical and Translational Data on Novel SIK2 Inhibitors at 21st Congress of European Crohn’s and Colitis Organisation (ECCO)
February 17, 2026
·
3 min read
Press Releases
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
February 18, 2026
·
4 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
Registration Link for Phio’s Presentation on Thursday, January 22 at 1:45 PM ET
January 15, 2026
·
5 min read
Press Releases
Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4) - January 21, 2026
January 22, 2026
·
1 min read
1 of 24,121
Next
